Q Bio
PrivateLast Round
Strategic
Jul 18, 2024
Est. Valuation
$140M
Total Funding Raised
$85M
Company Overview
Q Bio operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Strategic round in July 2024.
Q Bio is a healthcare technology company that operates a clinical digital twin platform to evaluate patients' medical histories and identify their current and future health risks through whole-body scans and advanced simulations.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2C
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Q Bio Comparables
Compare Q Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prenuvo | 83% | |
| Human Longevity | 78% | |
| Neko Health | 76% |
For institutional investors. Book with your work email.
Q Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 18, 2024 | ||||
| VC Round | Apr 29, 2021 | ||||
| Series B | Feb 20, 2020 | ||||
| Series A | Feb 1, 2018 | ||||
| Seed | Nov 2, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Q Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Strategic, VC Round, Series A, Seed, Series B |
| Beast Mode | Series B |
| SciFi Ventures | Series B, VC Round, Series A, Seed |
| Khosla Ventures | Strategic, Series B, VC Round, Series A, Seed |
| Founders Fund | Strategic, Series B, VC Round, Series A, Seed |
| Thirty Five Ventures | Series B, VC Round |
| Beast Ventures | Series B, VC Round, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2024
$27M raised with participation from Andreessen Horowitz and Founders Fund.
- Apr 29, 2021
Completed a VC Round funding round.
For institutional investors. Book with your work email.
Q Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Q Bio's valuation, stock price, and market status.
Is Q Bio a public or private company?
Q Bio is a private company.
What is the current stock price of Q Bio?
Q Bio is a private company, so its shares have no public market price. Caplight tracks Q Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Q Bio worth (valuation)?
Q Bio's valuation is estimated at $140.0M based on funding round data.
Can I buy Q Bio stock?
Q Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Q Bio's last funding round?
Q Bio's most recent funding round was Strategic on July 18, 2024.
Who are the main investors in Q Bio?
Key investors in Q Bio include Andreessen Horowitz, Kaiser Foundation Hospitals.
Will Q Bio IPO soon?
No public IPO plans have been announced for Q Bio.
How can I track Q Bio secondary market activity?
Caplight tracks bids, offers, and trades in Q Bio's shares on secondary markets.